Intent Solutions and NFANT Labs
We sat down with experts from two Atlanta area health technology companies, Intent Solutions and NFANT Labs. Joining us in studio were Lou Malice, Sam Zamarippa, and Tommy Cunningham. Intent Solutions is a start-up that is developing a device aimed at improving compliance with prescribed medication regimens, as well as helping to improve likelihood the intended person has access to the medicine.
In its early phase of development, Intent Solutions has positioned itself to be an effective tool for pharmaceutical research studies. In these studies, it is vital that participants adhere to the prescribed medication regimen in order to obtain the most effective and accurate test results.
The Intent Solutions device has a secure chamber that contains the pills for the particular prescription. Called “TAD” (standing for “take as directed”), the device utilizes fingerprint technology to identify the user before dispensing medication. Additionally, the TAD device is able to connect with the patient’s mobile device (and the prescribing entity) to share updates on efforts to access medication by unauthorized users, whether medication was dispensed, and it can send the patient reminders, prompting them to take their medication.
In this way, the TAD device facilitates medication research by improving compliance with the schedule the medication was intended to be taken on.
NFANT Labs has developed a device that uses sensors that can give a care giver visual feedback on a monitor regarding a NICU baby’s sucking patterns while feeding, a task that for many premies is challenging. Until now, the only way a practitioner could assess the sucking strength and patterns was to literally use a finger in the infant’s mouth.
The difficulty these young babies face is often related to a weak tongue, ineffective tongue movements, and uncoordinated swallowing timing. This predisposes them to consuming inadequate calories as well as creating the risk for aspiration pneumonia, both of which can lead to additional length of stay and even mortality.
The NFANT Labs monitor fits between the nipple and the bottle used to feed the child. It has a sensor that detects the up and down motion of the tongue, as well as negative pressure being generated by the suckling infant. It converts the data to wave forms on a monitor that the care giver can follow, allowing them to slow or pause feeding to allow the child to “catch up” with dispensed milk or to re-position them them to assess whether it leads to a more effective sucking pattern.
Lou Malice, CEO of Intent Solutions and NFANT Labs
Sam Zamarippa, VP of Strategy and Business Development, Intent Solutions
Tommy Cunningham, Co-founder of NFANT Labs